Opus Genetics, Stock Market Value
| IRD Stock | 1.10 0.01 0.90% |
| Symbol | Opus |
Opus Genetics, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth (0.68) | Return On Assets | Return On Equity |
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Opus Genetics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Opus Genetics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Opus Genetics,.
| 05/10/2025 |
| 08/08/2025 |
If you would invest 0.00 in Opus Genetics, on May 10, 2025 and sell it all today you would earn a total of 0.00 from holding Opus Genetics, or generate 0.0% return on investment in Opus Genetics, over 90 days. Opus Genetics, is related to or competes with Mosaic, Sealed Air, Ecolab, Regeneron Pharmaceuticals, Sonida Senior, Codexis, and Ardelyx. Opus Genetics, is entity of United States More
Opus Genetics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Opus Genetics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Opus Genetics, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.11 | |||
| Information Ratio | 0.0518 | |||
| Maximum Drawdown | 17.44 | |||
| Value At Risk | (4.39) | |||
| Potential Upside | 7.07 |
Opus Genetics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Opus Genetics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Opus Genetics,'s standard deviation. In reality, there are many statistical measures that can use Opus Genetics, historical prices to predict the future Opus Genetics,'s volatility.| Risk Adjusted Performance | 0.0715 | |||
| Jensen Alpha | 0.2248 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0578 | |||
| Treynor Ratio | 0.5346 |
Opus Genetics, Backtested Returns
Opus Genetics, appears to be relatively risky, given 3 months investment horizon. Opus Genetics, maintains Sharpe Ratio (i.e., Efficiency) of 0.0888, which implies the firm had a 0.0888 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Opus Genetics,, which you can use to evaluate the volatility of the company. Please evaluate Opus Genetics,'s Semi Deviation of 2.69, coefficient of variation of 1237.13, and Risk Adjusted Performance of 0.0715 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Opus Genetics, holds a performance score of 6. The company holds a Beta of 0.51, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Opus Genetics,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Opus Genetics, is expected to be smaller as well. Please check Opus Genetics,'s daily balance of power, market facilitation index, as well as the relationship between the expected short fall and value at risk , to make a quick decision on whether Opus Genetics,'s historical price patterns will revert.
Auto-correlation | 0.16 |
Very weak predictability
Opus Genetics, has very weak predictability. Overlapping area represents the amount of predictability between Opus Genetics, time series from 10th of May 2025 to 24th of June 2025 and 24th of June 2025 to 8th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Opus Genetics, price movement. The serial correlation of 0.16 indicates that over 16.0% of current Opus Genetics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Opus Genetics, lagged returns against current returns
Autocorrelation, which is Opus Genetics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Opus Genetics,'s stock expected returns. We can calculate the autocorrelation of Opus Genetics, returns to help us make a trade decision. For example, suppose you find that Opus Genetics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Opus Genetics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Opus Genetics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Opus Genetics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Opus Genetics, stock over time.
Current vs Lagged Prices |
| Timeline |
Opus Genetics, Lagged Returns
When evaluating Opus Genetics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Opus Genetics, stock have on its future price. Opus Genetics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Opus Genetics, autocorrelation shows the relationship between Opus Genetics, stock current value and its past values and can show if there is a momentum factor associated with investing in Opus Genetics,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Opus Genetics, is a strong investment it is important to analyze Opus Genetics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Opus Genetics,'s future performance. For an informed investment choice regarding Opus Stock, refer to the following important reports:Check out Opus Genetics, Correlation, Opus Genetics, Volatility and Opus Genetics, Alpha and Beta module to complement your research on Opus Genetics,. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Opus Genetics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.